Retraction to: Cav2.3 (R-type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo (Epilepsia, (2013), 54, (1542-1550), 10.1111/epi.12250);Ca v 2.3 (R-type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo

Epilepsia

Volumn 54, Issue 9, 2013, Pages 1542-1550

  Dibué, Maxine ^a,b   Kamp, Marcel A ^a,b   Alpdogan, Serdar ^a   Tevoufouet, Etienne E ^a   Neiss, Wolfram F ^a   Hescheler, Jürgen ^a   Schneider, Toni ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Antiepileptic drugs; Lamotrigine; Quantitative electroencephalography; R type; Toxicity

Indexed keywords

CALCIUM CHANNEL R TYPE; HARKOSERIDE; KAINIC ACID; LAMOTRIGINE; ACETAMIDE DERIVATIVE; ANTICONVULSIVE AGENT; CACNA1E PROTEIN, MOUSE; CATION TRANSPORT PROTEIN; DRUG DERIVATIVE; FRUCTOSE; TOPIRAMATE; TRIAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CALCIUM CURRENT; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROCORTICOGRAPHY; EPILEPSY; HIPPOCAMPAL CA1 REGION; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SEIZURE SUSCEPTIBILITY; SOMATOSENSORY CORTEX; TONIC CLONIC SEIZURE; ANIMAL; ANTIEPILEPTIC DRUGS; CAV2.3; DISEASE MODEL; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; METABOLISM; METHODOLOGY; QUANTITATIVE ELECTROENCEPHALOGRAPHY; R-TYPE; SEIZURE; TOXICITY;

ANTIEPILEPTIC DRUGS; CAV2.3; LAMOTRIGINE; QUANTITATIVE ELECTROENCEPHALOGRAPHY; R-TYPE; TOXICITY;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; CALCIUM CHANNELS, R-TYPE; CATION TRANSPORT PROTEINS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; FRUCTOSE; HIPPOCAMPUS; MICE; SEIZURES; TRIAZINES;

EID: 84883743265     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13378     Document Type: Erratum

References (30)

1. Allamand V, Sunada Y, Salih MAM, Straub V, Ozo CO, Al-Turaiki MHS, Akbar M, Kolo T, Colognato H, Zhang X, Sorokin LM, Yurchenco PD, Tryggvason K, Campbell KP,. (1997) Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2-chain. Hum Mol Genet 6: 747-752.
2. Beck H, Yaari Y,. (2012) Antiepileptogenesis, plasticity of AED targets, drug resistance, and targeting the immature brain. In, Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta A, (Eds) Jasper's basic mechanisms of the epilepsies. 4th ed. National Center for Biotechnology Information (US), Bethesda, MD.
3. Bragin A, Wilson CL, Almajano J, Mody I, Engel T,. (2004) High-frequency oscillations after status epilepticus: epileptogenesis and seizure genesis. Epilepsia 45: 1017-1023.
4. Chen J, Sochivko D, Beck H, Marechal D, Wiestler OD, Becker AJ,. (2001a) Activity-induced expression of common reference genes in individual CNS neurons. Lab Invest 81: 913-916.
5. Chen K, Aradi I, Thon N, Eghbal-Ahmadi M, Baram TZ, Soltesz I,. (2001b) Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat Med 7: 331-337.
6. Crespel A, Genton P, Berramdane M, Coubes P, Monicard C, Baldy-Moulinier M, Gelisse P,. (2005) Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology 65: 762-764.
7. Crumrine RC, Bergstrand K, Cooper AT, Faison WL, Cooper BR,. (1997) Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest. Stroke 28: 2230-2236.
8. Englund M, Hyllienmark L, Brismar T,. (2011) Effect of valproate, lamotrigine and levetiracetam on excitability and firing properties of CA1 neurons in rat brain slices. Cell Mol Neurobiol 31: 645-652.
9. Errington AC, Coyne L, Stohr T, Selve N, Lees G,. (2006) Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology 50: 1016-1029.
10. Errington AC, Stoehr T, Heers C, Lees G,. (2008) The Investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 73: 157-169.
11. Gasser T, Bacher P, Mocks J,. (1982) Transformations towards the normal-distribution of broad-band spectral parameters of the EEG. Electroencephalogr Clin Neurophysiol 53: 119-124.
12. Genton P,. (2000) When antiepileptic drugs aggravate epilepsy. Brain Dev 22: 75-80.
13. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O,. (1998) Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39: 508-512.
14. Hainsworth AH, McNaughton NC, Pereverzev A, Schneider T, Randall AD,. (2003) Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2 + channel currents. Eur J Pharmacol 467: 77-80.
15. Kuzmiski JB, Barr W, Zamponi GW, MacVicar BA,. (2005) Topiramate inhibits the initiation of plateau potentials in CA1 neurons by depressing R-type calcium channels. Epilepsia 46: 481-489.
16. Leach MJ, Baxter MG, Critchley MAE,. (1991) Neurochemical and behavioral-aspects of lamotrigine. Epilepsia 32: S4-S8.
17. Liang JM, Zhang YH, Wang JL, Pan H, Wu HS, Xu KM, Liu XY, Jiang YW, Shen Y, Wu XR,. (2006) New variants in the CACNA1H gene identified in childhood absence epilepsy. Neurosci Lett 406: 27-32.
18. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA,. (1996) Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16: 1337-1345.
19. N'Gouemo P, Yasuda R, Faingold CL,. (2010) Seizure susceptibility is associated with altered protein expression of voltage-gated calcium channel subunits in inferior colliculus neurons of the genetically epilepsy-prone rat. Brain Res 1308: 153-157.
20. 2+ channel α1E subunit. Eur J Neurosci 10: 916-925.
21. Pereverzev A, Mikhna M, Vajna R, Gissel C, Henry M, Weiergräber M, Hescheler J, Smyth N, Schneider T,. (2002) Disturbances in glucose-tolerance, insulin-release and stress-induced hyperglycemia upon disruption of the Cav2.3 (α1E) subunit of voltage-gated Ca2 + channels. Mol Endocrinol 16: 884-895.
22. Poolos NP, Migliore M, Johnston D,. (2002) Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nat Neurosci 5: 767-774.
23. Sperk G, Lassmann H, Baran H, Seitelberger F, Hornykiewicz O,. (1985) Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res 338: 289-295.
24. Traub RD, Whittington MA, Buhl EH, Lebeau FEN, Bibbig A, Boyd S, Cross H, Baldeweg T,. (2001) A possible role for gap junctions in generation of very fast EEG oscillations preceding the onset of, and perhaps initiating, seizures. Epilepsia 42: 153-170.
25. Tremblay E, Ben Ari Y,. (1984) Usefulness of parenteral kainic acid as a model of temporal lobe epilepsy. Rev Electroencephalogr Neurophysiol Clin 14: 241-246.
26. Wang YY, Khanna R,. (2011) Voltage-gated calcium channels are not affected by the novel anti-epileptic drug lacosamide. Transl Neurosci 2: 13-22.
27. 2+ channel. Epilepsia 47: 839-850.
28. v 2.3 E/R-type voltage-gated calcium channel. J Neurophysiol 97: 3660-3669.
29. Wierschke S, Gigout S, Horn P, Lehmann TN, Dehnicke C, Brauer AU, Deisz RA,. (2010) Evaluating reference genes to normalize gene expression in human epileptogenic brain tissues. Biochem Biophys Res Commun 403: 385-390.
30. Wisniewski RJ,. (2009) Protocol to enrich and analyze plasma membrane proteins. Methods Mol Biol 528: 127-134.